Abstract P2105: Polygenic risk scores for obstructive sleep apnea relying separately on BMI- adjusted and -unadjusted genetic associations reveal separate pathways of cardiovascular disease risk

T Tamar Sofer N Nuzulul Kurniansyah S Satu Strausz A Anne Justice (Geisinger, Danville, Pennsylvania, United States) Y Yana Hrytsenko (Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States) B Brian Cade (BRIGHAM AND WOMENS HOSPITAL, Boston, Massachusetts, United States) M Matthew Moll (Harvard Medical School, Boston, Massachusetts, United States) B Bernard Haring (Saarland University Hospital, Homburg, Germany) S Su Yon Jung (UCLA, Los Angeles, California, United States) L Laura Raffield J Jerome Rotter (The Lundquist Institute, Torrance, California, United States) S Stephen Rich S Sina Gharib (UNIVERSITY WASHINGTON, Shoreline, Washington, United States) T Traci Bartz (University of Washington, Seattle, Washington, United States) P Peter Liu (The Lundquist Institute, Torrance, California, United States) H Han Chen (GBRCE for Functional Molecular Engineering, LIFM, IGCME, School of Chemistry) L Lifang Hou D Daniel Levy (Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.) A Alanna Morrison (University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States) H Heather Ochs-Balcom (University at Buffalo, Buffalo, NY, USA.) P Peter Wilson A Allan Pack (University of Pennsylvania, Philadelphia, Pennsylvania, United States) H Hanna Ollila S Susan Redline D Daniel Gottlieb (Brigham and Women's Hospital, Boston, Massachusetts, United States)

Abstract

Background: OSA is a heterogeneous disease, with obesity a significant risk factor in many but not all cases of OSA, via increased airway collapsibility, reduced lung volumes, and possibly body fat distribution. Research question: We sought to develop PRSs that summarize the genetic liability to OSA that include and exclude obesity related pathways, and to study the associations of these PRSs with OSA comorbid cardiometabolic and CVD outcomes. Approach: Using 1.2 million race/ethnic diverse samples from the Million Veteran Program, FinnGen, TOPMed, All of Us (AoU), Geisinger’s MyCode, MGB Biobank, and the Human Phenotype Project (HPP), we developed, selected, and assessed PRSs for OSA, relying on genome wide association studies both adjusted and unadjusted for BMI: BMIadjOSA and BMIunadjOSA PRS. We tested their associations with cardiometabolic and CVD outcomes in AoU. Results: In association with OSA, adjusted odds ratios (ORs) per 1 standard deviation of the PRSs ranged from 1.38 to 2.75, all statistically significant (Figure). The associations of BMIadjOSA and BMIunadjOSA PRSs with CVD outcomes in AoU shared both common and distinct patterns. For example, BMIunadjOSA PRS was associated with type 2 diabetes, heart failure, and coronary artery disease, but the associations of BMIadjOSA PRS with these outcomes were statistically insignificant with estimated OR close to 1. In contrast, both BMIadjOSA and BMIunadjOSA PRSs were associated with hypertension and stroke. Sex stratified analyses revealed that BMIadjOSA PRS association with hypertension was driven by data from females: females had OR=1.1, p-value=0.002, but males OR=1.01 and statistically insignificant. OSA PRSs were also associated with dual-energy X-ray absorptiometry (DXA) body fat measures. In BMI adjusted analysis, BMIadjOSA PRS was associated with higher visceral adipose tissue (VAT) proportion of total body fat mass (TFM), with lower proportion of gynoid fat mass out of TFM, higher proportion of android fat mass out of TFM, and lower gynoid to android fat mass. In females only, the PRS was associated with higher VAT to SAT ratio (Figure). Conclusions: Distinct components of OSA genetic risk are related to obesity and body fat distribution, and may influence clinical outcomes. These may explain differing OSA risk and associations with cardiometabolic and CVD morbidities between sex groups.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue Suppl_1
Published March 11, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (25)

T

Tamar Sofer

N

Nuzulul Kurniansyah

S

Satu Strausz

A

Anne Justice

Geisinger, Danville, Pennsylvania, United States

Y

Yana Hrytsenko

Beth Israel Deaconess Medical Cente, Boston, Massachusetts, United States

B

Brian Cade

BRIGHAM AND WOMENS HOSPITAL, Boston, Massachusetts, United States

M

Matthew Moll

Harvard Medical School, Boston, Massachusetts, United States

B

Bernard Haring

Saarland University Hospital, Homburg, Germany

S

Su Yon Jung

UCLA, Los Angeles, California, United States

L

Laura Raffield

J

Jerome Rotter

The Lundquist Institute, Torrance, California, United States

S

Stephen Rich

S

Sina Gharib

UNIVERSITY WASHINGTON, Shoreline, Washington, United States

T

Traci Bartz

University of Washington, Seattle, Washington, United States

P

Peter Liu

The Lundquist Institute, Torrance, California, United States

H

Han Chen

GBRCE for Functional Molecular Engineering, LIFM, IGCME, School of Chemistry

L

Lifang Hou

D

Daniel Levy

Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

A

Alanna Morrison

University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States

H

Heather Ochs-Balcom

University at Buffalo, Buffalo, NY, USA.

P

Peter Wilson

A

Allan Pack

University of Pennsylvania, Philadelphia, Pennsylvania, United States

H

Hanna Ollila

S

Susan Redline

D

Daniel Gottlieb

Brigham and Women's Hospital, Boston, Massachusetts, United States